Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | EVP, Human Resources | December 02, 2024 | December 04, 2024 |
| Envista Holdings CorpNVST · Entity 4007 | Director | May 19, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date December 02, 2024 · Filed December 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,308 |
Ending reported balance
After 2024-12-02 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-12-02 · Exercise / conversion · Acquired 3,066 · Balance 35,094 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Row 2 · 2024-12-02 · Exercise / conversion · Acquired 1,197 · Balance 36,291 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. Row 3 · 2024-12-02 · Sale · Disposed 6,983 · Balance 29,308 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.26 · Expires 2026-02-22 | Direct | 0 |
Reported balance
After 2024-12-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-12-02 · Exercise / conversion · Disposed 3,066 · Balance 0 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.55 · Expires 2027-02-28 | Direct | 13,183 |
Reported balance
After 2024-12-02 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-12-02 · Exercise / conversion · Disposed 1,197 · Balance 13,183 F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023. F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.
F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
Envista Holdings Corp
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 59,940 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 59,940 F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2023 Filed Aug 15, 2023 20:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 11,671 | $51.30 | $598,677.95 |
DisclosureSEC source: 0001225208-23-008245 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,321 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $51.19 to $51.41, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2023 Filed Aug 15, 2023 20:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 2,960 | $13.08 | $38,716.80 |
DisclosureSEC source: 0001225208-23-008245 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| August 15, 2023 Filed Aug 15, 2023 20:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,448 | $16.31 | $56,236.88 |
DisclosureSEC source: 0001225208-23-008245 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 21:44 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,960 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001225208-23-007574 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,799 Underlying: Common Stock · 2,960 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 21:44 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $16.31 | $0.00 |
DisclosureSEC source: 0001225208-23-007574 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,242 Underlying: Common Stock · 3,448 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 21:44 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 11,671 | $52.85 | $616,773.84 |
DisclosureSEC source: 0001225208-23-007574 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,584 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $52.59 to $53.17, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 21:44 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 2,960 | $13.08 | $38,716.80 |
DisclosureSEC source: 0001225208-23-007574 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 21:44 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,448 | $16.31 | $56,236.88 |
DisclosureSEC source: 0001225208-23-007574 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 20:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,960 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001225208-23-006849 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,759 Underlying: Common Stock · 2,960 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 20:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $16.31 | $0.00 |
DisclosureSEC source: 0001225208-23-006849 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,690 Underlying: Common Stock · 3,448 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 20:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 11,671 | $53.24 | $621,359.37 |
DisclosureSEC source: 0001225208-23-006849 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,847 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $52.95 to $53.52, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 20:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 2,960 | $13.08 | $38,716.80 |
DisclosureSEC source: 0001225208-23-006849 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 20:53 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,448 | $16.31 | $56,236.88 |
DisclosureSEC source: 0001225208-23-006849 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:35 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 5,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-23-000048 · wf-form4_168504692996232.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,075 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,960 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001225208-23-006011 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,719 Underlying: Common Stock · 2,960 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $16.31 | $0.00 |
DisclosureSEC source: 0001225208-23-006011 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,138 Underlying: Common Stock · 3,448 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 11,671 | $53.49 | $624,333.14 |
DisclosureSEC source: 0001225208-23-006011 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,110 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.37 to $53.661, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 2,960 | $13.08 | $38,716.80 |
DisclosureSEC source: 0001225208-23-006011 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,448 | $16.31 | $56,236.88 |
DisclosureSEC source: 0001225208-23-006011 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,960 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001225208-23-004878 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,679 Underlying: Common Stock · 2,960 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $16.31 | $0.00 |
DisclosureSEC source: 0001225208-23-004878 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,586 Underlying: Common Stock · 3,448 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 11,671 | $51.96 | $606,422.83 |
DisclosureSEC source: 0001225208-23-004878 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,373 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $51.782 to $52.141, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 2,960 | $13.08 | $38,716.80 |
DisclosureSEC source: 0001225208-23-004878 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,448 | $16.31 | $56,236.88 |
DisclosureSEC source: 0001225208-23-004878 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c). Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:28 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,960 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001225208-23-003997 · doc4.xml · derivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,639 Underlying: Common Stock · 2,960 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:28 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $16.31 | $0.00 |
DisclosureSEC source: 0001225208-23-003997 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,034 Underlying: Common Stock · 3,448 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:28 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | SaleCommon Stock | 11,671 | $47.60 | $555,574.61 |
DisclosureSEC source: 0001225208-23-003997 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,636 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.41 to $47.73, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:28 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 2,960 | $13.08 | $38,716.80 |
DisclosureSEC source: 0001225208-23-003997 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:28 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 3,448 | $16.31 | $56,236.88 |
DisclosureSEC source: 0001225208-23-003997 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| February 21, 2023 Filed Feb 22, 2023 21:54 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionDeferred Stock Units · Derivative | 1,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002528 · doc4.xml · derivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,558 shares Expires 2023-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant. Read SEC document |
| February 21, 2023 Filed Feb 22, 2023 21:54 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 691 | $46.23 | $31,944.93 |
DisclosureSEC source: 0001225208-23-002528 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,899 Read SEC document |
| February 21, 2023 Filed Feb 22, 2023 21:54 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002528 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 18, 2023 Filed Feb 21, 2023 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionDeferred Stock Units · Derivative | 1,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002372 · doc4.xml · derivative · entry 9 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,853 Underlying: Common Stock · 1,853 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock. F5 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant. F5 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant. Read SEC document |
| February 18, 2023 Filed Feb 21, 2023 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 822 | $46.54 | $38,255.88 |
DisclosureSEC source: 0001225208-23-002372 · doc4.xml · nonDerivative · entry 6 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,032 Read SEC document |
| February 18, 2023 Filed Feb 21, 2023 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002372 · doc4.xml · nonDerivative · entry 5 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002372 · doc4.xml · derivative · entry 8 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 2,250 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 998 | $46.54 | $46,446.92 |
DisclosureSEC source: 0001225208-23-002372 · doc4.xml · nonDerivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,001 Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002372 · doc4.xml · nonDerivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002372 · doc4.xml · derivative · entry 7 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,153 Underlying: Common Stock · 2,050 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F3 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. F3 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 910 | $46.48 | $42,296.80 |
DisclosureSEC source: 0001225208-23-002372 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,749 Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:16 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002372 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 00:17 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionDeferred Stock Units · Derivative | 1,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002151 · doc4.xml · derivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,661 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 00:17 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 737 | $47.29 | $34,852.73 |
DisclosureSEC source: 0001225208-23-002151 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,609 Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 00:17 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002151 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 22:43 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantStock Option (Right to Buy) · Derivative | 22,014 | $0.00 Strike: $47.28 | $0.00 |
DisclosureSEC source: 0001225208-23-002035 · doc4.xml · derivative · entry 4 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,014 Underlying: Common Stock · 22,014 shares Expires 2033-02-14 F5 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 22:43 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantRestricted Stock Units · Derivative | 8,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002035 · doc4.xml · derivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,460 Underlying: Common Stock · 8,460 shares Expires 2027-02-14 F3 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 22:43 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantPerformance Share Units · Derivative | 7,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002035 · doc4.xml · derivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,202 Underlying: Common Stock · 7,202 shares Expires 2024-12-31 F1 · derivative.exercise_price: Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · shares: On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2024. F2 · derivative.exercise_date: On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2024. F2 · derivative.expiration_date: On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2024. F2 · balance_after: On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2024. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 22:43 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GiftCommon Stock | 2,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002035 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,685 Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 21:26 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionPerformance Share Units · Derivative | 6,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000049 · doc4.xml · derivative · entry 3 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,567 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. F1 · shares: On February 18, 2020, the reporting person was awarded a target number of performance share units under the Company's 2020 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2020 adjusted free cash flow measured against its 2020 financial plan over the one-year performance period ending December 31, 2020 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2021, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2022. F1 · derivative.exercise_date: On February 18, 2020, the reporting person was awarded a target number of performance share units under the Company's 2020 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2020 adjusted free cash flow measured against its 2020 financial plan over the one-year performance period ending December 31, 2020 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2021, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2022. F1 · derivative.expiration_date: On February 18, 2020, the reporting person was awarded a target number of performance share units under the Company's 2020 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2020 adjusted free cash flow measured against its 2020 financial plan over the one-year performance period ending December 31, 2020 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2021, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2022. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 21:26 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 3,100 | $46.27 | $143,437.00 |
DisclosureSEC source: 0001225208-23-000049 · doc4.xml · nonDerivative · entry 2 Carruthers Wendy · CIK 0001563565 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,880 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.